Indication
T-cell Lymphoblastic Lymphoma
1 clinical trial
1 product
Clinical trial
A Long-Term Safety Follow-Up Study for Patients Treated With Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007)Status: , Estimated PCD: 2037-07-01
Product
WU-CART-0071 clinical trial
1 product